{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:42:38Z","timestamp":1792658558515,"version":"4.5.0"},"reference-count":33,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Exp Pathol"],"DOI":"10.62347\/miva5829","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:35:56Z","timestamp":1790670956000},"page":"387-397","source":"Crossref","is-referenced-by-count":0,"title":["Distinct collagen resolution dynamics in early versus advanced liver fibrosis: a quantitative SHG\/TPEF study in mice"],"prefix":"10.62347","volume":"19","author":[{"given":"Hong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushuang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/hep.29009","article-title":"New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment","volume":"65","author":"Sun","year":"2017","unstructured":"Sun Y, Zhou J, Wang L, Wu X, Chen Y, Piao H, Lu L, Jiang W, Xu Y, Feng B, Nan Y, Xie W, Chen G, Zheng H, Li H, Ding H, Liu H, Lv F, Shao C, Wang T, Ou X, Wang B, Chen S, Wee A, Theise ND, You H and Jia J. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment. Hepatology 2017; 65: 1438-1450.","journal-title":"Hepatology"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Lassailly G, Caiazzo R, Ntandja-Wandji LC, Gnemmi V, Baud G, Verkindt H, Ningarhari M, Louvet A, Leteurtre E, Raverdy V, Dharancy S, Pattou F and Mathurin P. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology 2020; 159: 1290-1301, e1295.","DOI":"10.1053\/j.gastro.2020.06.006"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/hep.32204","article-title":"Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis","volume":"75","author":"Sanyal","year":"2022","unstructured":"Sanyal AJ, Anstee QM, Trauner M, Lawitz EJ, Abdelmalek MF, Ding D, Han L, Jia C, Huss RS, Chung C, Wong VW, Okanoue T, Romero-Gomez M, Muir AJ, Afdhal NH, Bosch J, Goodman Z, Harrison SA, Younossi ZM and Myers RP. Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis. Hepatology 2022; 75: 1235-1246.","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.7150\/thno.109771","article-title":"Hepatic stellate cell-derived microfibrillar-associated protein 2 prevents liver fibrosis by regulating extracellular matrix and inflammation","volume":"15","author":"Zhang","year":"2025","unstructured":"Zhang W, Wu W, Zhang N, Li H, Sun Y, Ge X, Han H, Chen S, Xu A, Komakula SSB, Wang C, Subramaniyam N, Han Q, Yang A, Yan X, Nieto N, You H and Chen W. Hepatic stellate cell-derived microfibrillar-associated protein 2 prevents liver fibrosis by regulating extracellular matrix and inflammation. Theranostics 2025; 15: 4033-4053.","journal-title":"Theranostics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/HEP.0000000000000563","article-title":"The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis","volume":"79","author":"Chang","year":"2024","unstructured":"Chang X, Lv C, Wang B, Wang J, Song Z, An L, Chen S, Chen Y, Shang Q, Yu Z, Tan L, Li Q, Liu H, Jiang L, Xiao G, Chen L, Lu W, Hu X, Dong Z, Chen Y, Sun Y, Wang X, Li Z, Chen D, You H, Jia J and Yang Y. The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis. Hepatology 2024; 79: 425-437.","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Sun Y, Chen W, Chen S, Wu X, Zhang X, Zhang L, Zhao H, Xu M, Chen Y, Piao H, Li P, Li L, Jiang W, Li X, Xing H, Liu X, Zhang Y, Wang B, Zhou J, Meng T, Zhao X, Shao C, Kong Y, Zhao X, Ou X, Liu C, Jia J and You H. Regression of liver fibrosis in patients on hepatitis B therapy is associated with decreased liver-related events. Clin Gastroenterol Hepatol 2024; 22: 591-601.e593.","DOI":"10.1016\/j.cgh.2023.11.017"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Liu Y, Meyer C, Xu C, Weng H, Hellerbrand C, ten Dijke P and Dooley S. Animal models of chronic liver diseases. Am J Physiol Gastrointest Liver Physiol 2013; 304: G449-468.","DOI":"10.1152\/ajpgi.00199.2012"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Mannan R, Misra V, Misra SP, Singh PA and Dwivedi M. A comparative evaluation of scoring systems for assessing necro-inflammatory activity and fibrosis in liver biopsies of patients with chronic viral hepatitis. J Clin Diagn Res 2014; 8: FC08-12.","DOI":"10.7860\/JCDR\/2014\/8704.4718"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ajcp\/aqx104","article-title":"Second harmonic generation reveals subtle fibrosis differences in adult and pediatric nonalcoholic fatty liver disease","volume":"148","author":"Liu","year":"2017","unstructured":"Liu F, Zhao JM, Rao HY, Yu WM, Zhang W, Theise ND, Wee A and Wei L. Second harmonic generation reveals subtle fibrosis differences in adult and pediatric nonalcoholic fatty liver disease. Am J Clin Pathol 2017; 148: 502-512.","journal-title":"Am J Clin Pathol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2009.12.009","article-title":"Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis","volume":"52","author":"Gailhouste","year":"2010","unstructured":"Gailhouste L, Le Grand Y, Odin C, Guyader D, Turlin B, Ezan F, Désille Y, Guilbert T, Bessard A, Frémin C, Theret N and Baffet G. Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis. J Hepatol 2010; 52: 398-406.","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s12072-024-10643-z","article-title":"Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments","volume":"18","author":"Chen","year":"2024","unstructured":"Chen S, Zhou J, Wu X, Meng T, Wang B, Liu H, Wang T, Zhao X, Zhao X, Kong Y, Ou X, Jia J, Sun Y and You H. Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments. Hepatol Int 2024; 18: 904-916.","journal-title":"Hepatol Int"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12072-019-09955-2","article-title":"SHG\/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies","volume":"13","author":"Wang","year":"2019","unstructured":"Wang B, Sun Y, Zhou J, Wu X, Chen S, Shi Y, Wu S, Liu H, Ren Y, Ou X, Jia J and You H. SHG\/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies. Hepatol Int 2019; 13: 501-509.","journal-title":"Hepatol Int"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Akbary K, Noureddin M, Yayun R, Tai D and Boudes P. Development of AI based fibrosis detection algorithm by SHG\/TPEF microscopy for fully quantified liver fibrosis assessment in MASH. Liver Int 2025; 45: e70258.","DOI":"10.1111\/liv.70258"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1111\/liv.16092","article-title":"Digital quantitation of bridging fibrosis and septa reveals changes in natural history and treatment not seen with conventional histology","volume":"44","author":"Naoumov","year":"2024","unstructured":"Naoumov NV, Kleiner DE, Chng E, Brees D, Saravanan C, Ren Y, Tai D and Sanyal AJ. Digital quantitation of bridging fibrosis and septa reveals changes in natural history and treatment not seen with conventional histology. Liver Int 2024; 44: 3214-3228.","journal-title":"Liver Int"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cgh.2025.06.042","article-title":"Repeatability and reproducibility of artificial imaging-based digital pathology for the evaluation of liver fibrosis","volume":"24","author":"Ren","year":"2026","unstructured":"Ren Y, Chang JPE, Tai D, Filozof CM, Kleiner DE and Sanyal AJ. Repeatability and reproducibility of artificial imaging-based digital pathology for the evaluation of liver fibrosis. Clin Gastroenterol Hepatol 2026; 24: 713-722.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Khendek L, Castro-Rojas C, Nelson C, Alquraish M, Karns R, Kasten J, Teng X, Miethke AG and Taylor AE. Quantitative fibrosis identifies biliary tract involvement and is associated with outcomes in pediatric autoimmune liver disease. Hepatol Commun 2024; 9: e0594.","DOI":"10.1097\/HC9.0000000000000594"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/labinvest.2016.128","article-title":"Automated evaluation of liver fibrosis in thioacetamide, carbon tetrachloride, and bile duct ligation rodent models using second-harmonic generation\/two-photon excited fluorescence microscopy","volume":"97","author":"Liu","year":"2017","unstructured":"Liu F, Chen L, Rao HY, Teng X, Ren YY, Lu YQ, Zhang W, Wu N, Liu FF and Wei L. Automated evaluation of liver fibrosis in thioacetamide, carbon tetrachloride, and bile duct ligation rodent models using second-harmonic generation\/two-photon excited fluorescence microscopy. Lab Invest 2017; 97: 84-92.","journal-title":"Lab Invest"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1038\/srep04636","article-title":"Experimenting liver fibrosis diagnostic by two photon excitation microscopy and Bag-of-Features image classification","volume":"4","author":"Stanciu","year":"2014","unstructured":"Stanciu SG, Xu S, Peng Q, Yan J, Stanciu GA, Welsch RE, So PT, Csucs G and Yu H. Experimenting liver fibrosis diagnostic by two photon excitation microscopy and Bag-of-Features image classification. Sci Rep 2014; 4: 4636.","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/jhep.2003.50067","article-title":"DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells","volume":"37","author":"Yata","year":"2003","unstructured":"Yata Y, Scanga A, Gillan A, Yang L, Reif S, Breindl M, Brenner DA and Rippe RA. DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology 2003; 37: 267-276.","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jhep.2014.02.015","article-title":"qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients","volume":"61","author":"Xu","year":"2014","unstructured":"Xu S, Wang Y, Tai DCS, Wang S, Cheng CL, Peng Q, Yan J, Chen Y, Sun J, Liang X, Zhu Y, Rajapakse JC, Welsch RE, So PTC, Wee A, Hou J and Yu H. qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol 2014; 61: 260-269.","journal-title":"J Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P, Qian X, Wang M, He X, Wang T, Li S and Song X. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta 2022; 1: e36.","DOI":"10.1002\/imt2.36"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Zhang N, Yang A, Zhang W, Li H, Xu A, Yan X, Han Q, Wang B, You H and Chen W. Crosstalk of lysyl oxidase-like 1 and lysyl oxidase prolongs their half-lives and regulates liver fibrosis through Notch signal. Hepatol Commun 2024; 8: e0391.","DOI":"10.1097\/HC9.0000000000000391"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/cells13050438","article-title":"Exploring extracellular matrix crosslinking as a therapeutic approach to fibrosis","volume":"13","author":"Lloyd","year":"2024","unstructured":"Lloyd SM and He Y. Exploring extracellular matrix crosslinking as a therapeutic approach to fibrosis. Cells 2024; 13: 438.","journal-title":"Cells"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Kong W, Lyu C, Liao H and Du Y. Collagen crosslinking: effect on structure, mechanics and fibrosis progression. Biomed Mater 2021; 16.","DOI":"10.1088\/1748-605X\/ac2b79"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41379-018-0059-x","article-title":"Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients","volume":"31","author":"Wang","year":"2018","unstructured":"Wang B, Sun Y, Zhou J, Wu X, Chen S, Wu S, Liu H, Wang T, Ou X, Jia J and You H. Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients. Mod Pathol 2018; 31: 1567-1577.","journal-title":"Mod Pathol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"114472","DOI":"10.1016\/j.biopha.2023.114472","article-title":"Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis","volume":"161","author":"Shan","year":"2023","unstructured":"Shan L, Wang F, Zhai D, Meng X, Liu J and Lv X. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis. Biomed Pharmacother 2023; 161: 114472.","journal-title":"Biomed Pharmacother"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1002\/ptr.7959","article-title":"Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis","volume":"37","author":"Sabir","year":"2023","unstructured":"Sabir U, Gu HM and Zhang DW. Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis. Phytother Res 2023; 37: 4932-4962.","journal-title":"Phytother Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","unstructured":"Taru V, Szabo G, Mehal W and Reiberger T. Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation. J Hepatol 2024; 81: 895-910.","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"101406","DOI":"10.1016\/j.jcmgh.2024.101406","article-title":"Sphingosine kinase 1 aggravates liver fibrosis by mediating macrophage recruitment and polarization","volume":"18","author":"Ding","year":"2024","unstructured":"Ding X, Zhang X, Cao J, Chen S, Chen Y, Yuan K, Chen B, Yang G, Li S, Yang J, Wang G, Tacke F and Lan T. Sphingosine kinase 1 aggravates liver fibrosis by mediating macrophage recruitment and polarization. Cell Mol Gastroenterol Hepatol 2024; 18: 101406.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.31236","article-title":"Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis","volume":"72","author":"Chen","year":"2020","unstructured":"Chen W, Yang A, Jia J, Popov YV, Schuppan D and You H. Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis. Hepatology 2020; 72: 729-741.","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","volume":"66","author":"Ikenaga","year":"2017","unstructured":"Ikenaga N, Peng ZW, Vaid KA, Liu SB, Yoshida S, Sverdlov DY, Mikels-Vigdal A, Smith V, Schuppan D and Popov YV. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. Gut 2017; 66: 1697-1708.","journal-title":"Gut"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"An P, Wei G, Huang P, Matta H, Li W, Lin Y, Wang J, Gretchen B and Popov YV. A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms. Hepatol Commun 2025; 10: e0863.","DOI":"10.1097\/HC9.0000000000000863"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1665-2681(19)31740-5","article-title":"Reversibility of liver fibrosis","volume":"8","author":"Ramachandran","year":"2009","unstructured":"Ramachandran P and Iredale JP. Reversibility of liver fibrosis. Ann Hepatol 2009; 8: 283-291.","journal-title":"Ann Hepatol"}],"container-title":["International Journal of Clinical and Experimental Pathology"],"original-title":[],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:30:00Z","timestamp":1792657800000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ijcep\/19\/9\/ijcep0174020.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.62347\/miva5829","relation":{},"ISSN":["1936-2625"],"issn-type":[{"value":"1936-2625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}